Merck & Co., Inc. (MRK) vs NVIDIA Corporation (NVDA)

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.

NVIDIA is a leading designer of graphics processing units (GPUs). Historically, GPUs were used to improve performance and user experience across computing platforms, especially in PC gaming. Over time, GPUs have become essential semiconductors for artificial intelligence, powering large language models and other advanced AI workloads. In addition to AI-focused GPUs, NVIDIA provides its CUDA software platform, which supports AI model development and training. The company is also expanding its data center networking solutions, helping connect GPUs to manage increasingly complex workloads.